🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +17.99% on $BVS in just 19h 7m.
OCU
$OCUL
🔒 US EquitiesOcular Therapeutix Inc
AVG HISTORICAL GAP
-1.05%
MAX GAP RECORD
-9.23%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $OCUL
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$OCUL
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 03, 2026 Earnings Release 2026-08-03 (UNDETERMINED) |
+0.00%
|
| May 05, 2026 Earnings Release 2026-05-05 (UNDETERMINED) |
+0.00%
|
| Feb 05, 2026 Earnings Release 2026-02-05 (BEFORE OPEN) |
+3.51%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (BEFORE OPEN) |
-1.84%
|
| Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN) |
-9.23%
|
| May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN) |
-1.03%
|
| Mar 03, 2025 Earnings Release 2025-03-03 (BEFORE OPEN) |
-2.80%
|
| Nov 14, 2024 Earnings Release 2024-11-14 (AFTER CLOSE) |
+1.11%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.3%
Bullish Gaps (5)
Bearish Gaps (7)
Neutral / Flat (1)
📖 Intelligence Summary
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗